Peritoneal Cancer
📧 Sign up to get email alerts when something new happens for Peritoneal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2) [Phase 1, Phase 2]
An update on the OVATION 2 study evaluating IMNN-001 (GEN-1) with neoadjuvant chemotherapy for epithelial ovarian cancer, fallopian tube can…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer [Phase 3]
A Phase 3 clinical trial evaluating IMNN-001 in combination with standard neoadjuvant and adjuvant chemotherapy for newly diagnosed advanced…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer (HGSEC): The t-BRCA Study
This clinical trial update reports the completed status of the t-BRCA study evaluating upfront BRCA testing in patients with high-grade sero…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: ONC-392 and Pembrolizumab in Platinum Resistant Ovarian Cancer [Phase 2]
A Phase 2 trial evaluating ONC-392 in combination with pembrolizumab for platinum-resistant ovarian cancer is active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib [Phase 2]
This Clinical Trial Update reports a Phase 2 study evaluating maintenance therapy with the antibody-drug conjugate mirvetuximab soravtansine…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors [NA]
A ClinicalTrials.gov update for REVITALIZE, a randomized trial to reduce fatigue in adults with ovarian cancer on PARP inhibitors; the study…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy [Phase 2]
Phase 2 clinical trial update comparing sacituzumab govitecan with bevacizumab to standard chemotherapy for recurrent platinum-sensitive ova…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence [Phase 2]
This entry describes a Phase 2 clinical trial of an IGFBP-2 vaccine to prevent ovarian cancer progression in patients with serologic evidenc…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers
This completed NCI clinical trial reports on predictors of relapse in fallopian tube cancer, peritoneal cancer, and epithelial ovarian cance…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluating Ubamatamab in combination therapy for adults with platinum-resistant ovarian cancer; recruitment is ongo…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer [Phase 1]
A Phase 1 clinical trial evaluating Azenosertib (ZN-c3) in patients with epithelial ovarian cancer and other solid tumors is currently recru…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT [Phase 1]
Phase I pilot study to characterize biodistribution, metabolism, and excretion of the novel PET radiotracer [18F]Fluorthanatrace (FTT) using…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies [Phase 2]
This Phase 2 trial investigates changes in disease activity and safety in adults with gynecologic cancers treated with IMGN151, either alone…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial is evaluating a cancer vaccine therapy in combination with pembrolizumab for advanced fallopian tube, primary per…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer. [Phase 2]
Clinical trial update for a Phase 2 study evaluating a combination of oregovomab and niraparib in platinum-sensitive recurrent ovarian cance…
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 1]
Phase 1 trial evaluating a carboplatin/gemcitabine hydrochloride/berzosertib combination in patients with recurrent or metastatic ovarian, f…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas [Phase 2]
Clinical trial BrUOG 354 assesses nivolumab with or without ipilimumab in ovarian and extrarenal (clear cell) carcinomas; the Phase 2 study …
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer [Phase 1]
FT536 is being evaluated in a Phase 1 trial for recurrent ovarian cancer, fallopian tube cancer, and primary peritoneal cancer, and the stud…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Drug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 1]
Clinical trial update for a Phase 1 drug-drug interaction study evaluating AZD5335 with itraconazole in ovarian-, fallopian tube-, or primar…
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib [Phase 2]
A Phase II trial evaluating nivolumab, bevacizumab, and rucaparib in peritoneal cancer, ovarian cancer, and fallopian tube cancer; results h…
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer [Phase 2]
Phase 2 trial evaluating oregovomab in combination with chemotherapy in the neoadjuvant setting for newly diagnosed advanced epithelial ovar…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery [Phase 2]
Phase 2 clinical trial update on acute normovolemic hemodilution in patients with ovarian cancer undergoing cytoreductive surgery; currently…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery [Phase 3]
A Phase 3 trial of oregovomab plus chemotherapy for newly diagnosed advanced epithelial ovarian cancer after optimal debulking surgery is cu…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Using Aspirin to Improve Immunological Features of Ovarian Tumors [EARLY_Phase 1]
Phase 1 trial is exploring whether aspirin can improve the immunological features of ovarian tumors and related cancers. The study is curren…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Prospective Clinico-biological Database of Patients With Ovarian and/or Peritoneal and/or Fallopian Tube Carcinoma [NA]
A prospective clinico-biological database study for patients with ovarian cancer, fallopian tube cancer, or peritoneal cancer is currently r…